Dong-A ST Co., Ltd.

Dong-A ST Co., Ltd. is a South Korean pharmaceutical company primarily engaged in the research, development, production, and distribution of healthcare products. Established in 1932, the company focuses on the manufacture of prescription drugs, over-the-counter medications, and medical devices, playing a pivotal role in the healthcare sector within and beyond South Korea. Dong-A ST is renowned for its innovative drug portfolio, which includes treatments for hypertension, diabetes, and infectious diseases. It also actively invests in biologics and biosimilars, seeking to expand its reach in the global pharmaceutical market. The company's research endeavors are complemented by strategic partnerships and collaborations with international biotechnology and life sciences firms, enhancing its expertise in drug development and commercialization. As a key player in the pharmaceutical industry, Dong-A ST Co., Ltd. contributes significantly to advancements in medical treatments and healthcare solutions, impacting both local markets and the wider global community.